Insider Transactions in Q2 2022 at Emergent Bio Solutions Inc. (EBS)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2022
|
Kathryn C Zoon Director |
SELL
Open market or private sale
|
Direct |
1,173
-5.63%
|
$36,363
$31.52 P/Share
|
|
May 26
2022
|
Kathryn C Zoon Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,446
+28.85%
|
-
|
|
May 26
2022
|
Louis W Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,446
+13.65%
|
-
|
|
May 26
2022
|
Ronald Richard Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,446
+27.97%
|
-
|
|
May 26
2022
|
Marvin L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,446
+33.06%
|
-
|
|
May 26
2022
|
George A Joulwan Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,446
+17.35%
|
-
|
|
May 26
2022
|
Jerome M Hauer Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,446
+26.31%
|
-
|
|
May 26
2022
|
Zsolt Harsanyi Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
8,446
+18.16%
|
-
|
|
May 24
2022
|
Kathryn C Zoon Director |
SELL
Open market or private sale
|
Direct |
1,996
-13.88%
|
$69,860
$35.53 P/Share
|
|
Apr 08
2022
|
Coleen Glessner EVP, Quality & Ethics, and CPL |
BUY
Grant, award, or other acquisition
|
Direct |
11,826
+41.67%
|
-
|
|
Apr 02
2022
|
Keith Katkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,595
+50.0%
|
-
|